Acute Hepatic Porphyria (AHP)

Sponsored diagnostic testing programs for Acute Hepatic Porphyria (AHP)

Acute hepatic porphyria (AHP) is a group of rare inherited disorders caused by enzyme defects in the heme pathway, leading to buildup of neurotoxic intermediates. Attacks may include severe abdominal pain and neurologic or autonomic symptoms. Because signs can mimic other conditions, genetic testing helps confirm the diagnosis.

1 program found for Acute Hepatic Porphyria (AHP)

Featured Programs

1 program
Acute Hepatic Porphyria (AHP)
Alnylam Act
Sponsored by
Alnylam Pharmaceuticals

Alnylam Act® hATTR Amyloidosis

This sponsored program offers complimentary TTR gene testing and genetic counseling for eligible patients with suspected hereditary ATTR (hATTR) amyloidosis. It enables you to confirm or rule out the diagnosis, facilitate family risk assessment, and align patient management accordingly. All services are provided at no cost to the patient, provider, or payer.

Metabolic
ViewOrder
Performing labPrevention Genetics
Verified programFeatured